INNOVHEART
Manufacturing · Italy · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Via Giovannino De Grassi 11, Milano, Lom...Phone Number
(856) 383-0110Website
www.innovheart.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About INNOVHEART
InnovHeart s.r.l, with locations in Milan, Italy, and Newton, Mass., USA, develops Transcatheter Mitral Valve Replacement systems (TMVR) to treat patients suffering from mitral valve disease. The company is conducting clinical trials of its novel Saturn TMVR system. Saturn is a low-profile mitral heart valve designed for trans-apical or trans-septal delivery.Explore more
INNOVHEART Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is INNOVHEART your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on INNOVHEART recently announced quarterly report
Check out if INNOVHEART is spiking on competitors!
Click to see if INNOVHEART had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once INNOVHEART has new funding data
Check if INNOVHEART has recently received funding, and reach out quickly before it becomes old news!
INNOVHEART, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at INNOVHEART
Product Launch: Get notified when INNOVHEART launches new products
Recommended Actions
Reach out to Masked Content who joined INNOVHEART as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
INNOVHEART is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
INNOVHEART is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about INNOVHEART.
INNOVHEART financials insights
Gather financial insights about INNOVHEART, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Multiple Rounds
$39.8M
2022
Series C
$55M
INNOVHEART Tech Stack
A closer look at the technologies used by INNOVHEART
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Research & Development, Product Management, Medical Research, Clinical Operations
INNOVHEART News & Media
InnovHeart Announces First-In-Human Trans-Septal Implantation of Saturn Mitral Valve Replacement
NEWTON, Mass. and MILAN, May 30, 2024 /PRNewswire/ -- InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral regurgitation (MR), announced today the first trans-septal clinical trial implant with the proprietary Saturn...TMVR Firm InnovHeart Names David Wilson CEO - Medical Product Outsourcing
Wilson was president of Global Plasma at Haemonetics and worked at J&J for two decades.InnovHeart appoints David Wilson as Chief Executive Officer
- Industry Leader to Guide Company and the Saturn TMVR Program in its Next Phase of Growth NEWTON, Mass., March 30, 2022 /PRNewswire/ -- InnovHeart s.r.l., a developer of the novel Saturn Transcatheter Mitral Valve Replacement (TMVR) system for the treatment of mitral regurgitation,...InnovHeart raises $55 million in Series C financing to further develop the Trans-septal Saturn Transcatheter Mitral Valve Replacement System
MILAN, Jan. 27, 2022 /PRNewswire/ -- InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral valve disease, announces the closing of its Series C financing with granting an exclusive licensing agreement to Grand...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding INNOVHEART
Sign Up For FreeTo access detailed company insights
InnovHeart s.r.l, with locations in Milan, Italy, and Newton, Mass., USA, develops Transcatheter Mitral Valve Replacement systems (TMVR) to treat patients suffering from mitral valve disease. The company is conducting clinical trials of its novel Saturn TMVR system. Saturn is a low-profile mitral heart valve designed for trans-apical or trans-septa... Read More
